Drug Chatter -- Tracking biopharma stock chatter

Profile for Eagle Pharmaceuticals, Inc. (EGRX)

« Back to company index

EGRX Chatter Timeline

Stock Ticker for EGRX

Most Active Tweeters for EGRX

UserTweets
@confcalltran 4
@MariaDa18810214 4
@StockTexts 4
@tymorapro 3
@dispatchtribune 3

Recent Tweets for EGRX

dispatchtribune @dispatchtribune
Eagle Pharmaceuticals $EGRX Earning Somewhat Favorable News Coverage, Study Shows https://t.co/laBrMdYd6R
January 17th 2018, 7:01am
efinancialpub @efinancialpub
RT @AmericanBanking: Eagle Pharmaceuticals, Inc. $EGRX Receives Consensus Recommendation of “Hold” from Analysts https://t.co/9SmA3a8Gdq #s…
January 16th 2018, 12:01pm
dispatchtribune @dispatchtribune
Eagle Pharmaceuticals, Inc. $EGRX Receives Consensus Recommendation of “Hold” from Analysts https://t.co/o8hbtnWbxD
January 16th 2018, 12:01pm
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals, Inc. $EGRX Receives Consensus Recommendation of “Hold” from Analysts https://t.co/9SmA3a8Gdq #stocks
January 16th 2018, 12:01pm
dailypoliticaln @dailypoliticaln
Eagle Pharmaceuticals, Inc. $EGRX Given Consensus Recommendation of “Hold” by Brokerages https://t.co/bCPhuC61h0
January 16th 2018, 12:01pm
finboxio @finboxio
Eagle Pharmaceuticals, Inc. $EGRX could jump soon... Stock looks 10% undervalued https://t.co/b4Xa5zR84V
January 15th 2018, 5:01pm
MarieSm76375904 @MarieSm76375904
Proquest Associates Iv Lowered Eagle Pharmaceuticals $EGRX Holding as Share Price Rose ...
January 15th 2018, 3:01pm
WatchlistN @WatchlistN
Schwab Charles Investment Management Inc. Has $3.62 Million Position in Eagle Pharmaceuticals, Inc. $EGRX https://t.co/VLrMrtOYzJ
January 14th 2018, 6:01am
ConsumerFeed @ConsumerFeed
Zacks Investment Research Downgrades Eagle Pharmaceuticals $EGRX to Hold https://t.co/SeK9t358un
January 13th 2018, 1:01pm
WeekHerald @WeekHerald
Zacks Investment Research Downgrades Eagle Pharmaceuticals $EGRX to Hold https://t.co/eS6BAd2Svv
January 13th 2018, 1:01pm
dispatchtribune @dispatchtribune
Zacks Investment Research Lowers Eagle Pharmaceuticals $EGRX to Hold https://t.co/u9MesNRW1L
January 12th 2018, 2:01pm
tymorapro @tymorapro
$EGRX: Exc 1MoHIGH=63.10, hits:1, Rng:16%, ch:+0.9%, 1phNewHi+, PrvCHi+, allTFs+, lowFlt:11M, HiPctSht[33%:18d], DyVol:39T:0.2x:0.2x
January 12th 2018, 11:01am
MariaDa18810214 @MariaDa18810214
Holder Opaleye Management Has Boosted Eagle Pharmaceuticals $EGRX Position https://t.co/9pbIGKHgeL
January 12th 2018, 8:01am
WeekHerald @WeekHerald
Eagle Pharmaceuticals $EGRX Getting Favorable News Coverage, Study Finds https://t.co/ljwf4Jlo7i
January 12th 2018, 7:01am
TheMarketsDaily @TheMarketsDaily
Eagle Pharmaceuticals $EGRX Receiving Favorable Media Coverage, Study Shows https://t.co/ZBHVmXSjG3
January 12th 2018, 4:01am
TraderMN1 @TraderMN1
$EGRX ascending triangle. Next stop $70.
January 11th 2018, 8:01pm
tymorapro @tymorapro
$EGRX: Exc 1MoHIGH=61.40, hits:1, Rng:14%, ch:+3.6%, 3NewHi, 7:5Accel+, allTFs+, lowFlt:11M, HiPctSht[33%:19d], DyVol:101T:1.1x:0.5x
January 11th 2018, 1:01pm
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals $EGRX Stock Rating Lowered by Zacks Investment Research https://t.co/GfNcyDnFnk
January 11th 2018, 12:01pm
StockTipRobot @StockTipRobot
Found a note outside Berkshire Hathaway's office. It said to consider buying Eagle Pharmaceuticals $EGRX #Advice
January 11th 2018, 10:01am
MariaDa18810214 @MariaDa18810214
Eagle Pharmaceuticals $EGRX Stock Value Rose While Proquest Associates Iv Has Decreased Position by $215.0...
January 11th 2018, 9:01am
ZolmaxNews @ZolmaxNews
Eagle Pharmaceuticals $EGRX Stock Rating Lowered by Zacks Investment Research https://t.co/D7JWamECFc
January 10th 2018, 5:01pm
MariaDa18810214 @MariaDa18810214
Proquest Associates Iv Has Lowered Stake in Eagle Pharmaceuticals $EGRX by $215.08 Million as Share Price ...
January 10th 2018, 5:01am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals $EGRX Lowered to Hold at Zacks Investment Research https://t.co/z9JlTgTslw #stocks
January 9th 2018, 11:01pm
intercooleronli @intercooleronli
Eagle Pharmaceuticals $EGRX Downgraded to Hold at Zacks Investment Research https://t.co/vGF1YzJGui #investing
January 9th 2018, 10:01pm
ledgerzette @ledgerzette
Eagle Pharmaceuticals $EGRX Downgraded to Hold at Zacks Investment Research https://t.co/VJJEMGkdo8
January 9th 2018, 10:01pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/buGdFnEsnP
January 9th 2018, 5:01pm
InsiderAlertsIA @InsiderAlertsIA
$EGRX: New Insider Filing on EVP & Chief Scientific Officer STEVEN L. KRILL: https://t.co/pZKf76Kt6L
January 9th 2018, 5:01pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/nHZXOGqOzx
January 9th 2018, 5:01pm
confcalltran @confcalltran
Eagle Pharmaceuticals director was just granted 10,000 options https://t.co/KbbJHpawb0 $EGRX
January 9th 2018, 5:01pm
confcalltran @confcalltran
. Iridian Asset Management LLC just provided an update on share ownership of Eagle Pharmaceutic https://t.co/n5FIjtVxI0 $EGRX
January 8th 2018, 4:01pm
HedgeMind @HedgeMind
$EGRX David Cohen's Iridian Asset fund raised stake by 84% 668K shs to 1.5M shs 10.10% of O/S as of 12/31 after th… https://t.co/uI6AAn7XM7
January 8th 2018, 4:01pm
fintel_io @fintel_io
Iridian Asset Management Llc/ct has filed a new 13G, reporting 10.1% ownership in $EGRX - https://t.co/BaYZq4BjV0
January 8th 2018, 4:01pm
confcalltran @confcalltran
. Iridian Asset Management LLC just provided an update on share ownership of Eagle Pharmaceutic https://t.co/EDTShrwWeM $EGRX
January 8th 2018, 3:01pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form SC 13G https://t.co/mUBREPVyDR
January 8th 2018, 3:01pm
marketexclusive @marketexclusive
Eagle Pharmaceuticals,Inc. (NASDAQ:EGRX) Files An 8-K Regulation FD Disclosure https://t.co/NY101l0xL9 $EGRX
January 8th 2018, 11:01am
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/Xl0NCmkhfh
January 8th 2018, 10:01am
confcalltran @confcalltran
Eagle Pharmaceuticals January 2018 https://t.co/CcDggy4pHA $EGRX
January 8th 2018, 10:01am
QLFilings @QLFilings
$EGRX filed Form 8-K with the SEC. Most mentioned words: eagle, ryanodex, market, product, fda
January 8th 2018, 10:01am
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals $EGRX Given Daily Coverage Optimism Rating of 0.25 https://t.co/lwmT0DU0gK
January 7th 2018, 6:01am
MariaDa18810214 @MariaDa18810214
Eagle Pharmaceuticals $EGRX Holder Proquest Associates Iv Has Cut Its Holding https://t.co/8gpDn3fIW1
January 5th 2018, 8:01am
tymorapro @tymorapro
$EGRX: Exc 1WkHIGH=59.19, hits:1, Rng:11%, ch:+0.9%, AtgPivH3, 11:3Accel+, tf:0111111, lowFlt:11M, HiPctSht[33%:14d], DyVol:102T:0.5x:0.4x
January 4th 2018, 1:01pm
Margare30926081 @Margare30926081
Eagle Pharmaceuticals $EGRX Market Valuation Rose While First Eagle Investment Management Has Decreased Sta...
January 3rd 2018, 10:01am
tymorapro @tymorapro
$EGRX: Exc 1WkHIGH=56.55, hits:1, Rng:7%, ch:+6.0%, 1NewHi+, PrvCLo-, AtPivR2, 6:2Accel+, tf:0111111, lowFlt:11M, HiPctSht[33%:14d]
January 2nd 2018, 11:01am
livetraderalrt @livetraderalrt
$EGRX Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference https://t.co/d7TFTmYfiN
January 2nd 2018, 7:01am
SleekMoneycom @SleekMoneycom
Eagle Pharmaceuticals, Inc. $EGRX Holdings Reduced by GSA Capital Partners LLP https://t.co/qvbndpJdZZ
January 2nd 2018, 7:01am
MrCDanso @MrCDanso
Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference $EGRX https://t.co/CUgg75Gpxm
January 2nd 2018, 6:01am
stockboardinc @stockboardinc
$EGRX Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference... - https://t.co/JkSWRwyTgA
January 2nd 2018, 6:01am
ZolmaxNews @ZolmaxNews
Cubist Systematic Strategies LLC Purchases 2,852 Shares of Eagle Pharmaceuticals, Inc. $EGRX https://t.co/0TEBri8WvU
January 2nd 2018, 4:01am
IRAMarketReport @IRAMarketReport
Eagle Pharmaceuticals $EGRX Receiving Somewhat Favorable Press Coverage, Study Finds https://t.co/3OvsmyNpJb
January 2nd 2018, 3:01am
chaffeybreeze @chaffeybreeze
Eagle Pharmaceuticals $EGRX Receiving Somewhat Favorable Press Coverage, Study Finds https://t.co/GA0Ivw1aBs
January 2nd 2018, 3:01am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.